Episode Player
Unraveling Cryptogenic Stroke
The Neurotransmitters: Clinical Neurology Education
Chapters
0:00
Defining Cryptogenic Stroke And ESUS
2:15
Why Anticoagulation Isnβt The Default
3:40
When To Hunt For Rare Causes
6:50
Smarter History Taking For Clotting Risk
9:50
Stop The Scattershot Thrombophilia Panel
13:05
APLS: Tests, Risk Tiers, And Treatment
20:05
AdamTS13, TTP, And Atypical Presentations
27:00
JAK2, MPNs, And Stroke Patterns
31:40
Cancer-Associated Stroke And Workup
37:20
Drug Effects, Anticoagulants, And Tradeoffs
41:30
PFO: Who To Image And Who To Close
48:45
TEE vs TTE And Practical Logistics
53:20
The Judgment Calls That Keep Us Up
57:35
Sickle Cell Disease And Stroke Pathways
1:07:30
Teaming With Hematology And Follow-Up
1:08:20
Closing Remarks And Where To Find Us
The Neurotransmitters: Clinical Neurology Education
Unraveling Cryptogenic Stroke
Dec 09, 2025
Episode 64
Michael Kentris
Dr. Johanna Seiden joins us to talk about a challenging topic, cryptogenic stroke. What do you do when you need to look beyond the obvious causes? Dr. Seiden gives some useful recommendations and idea for further investigation in some of the toughest stroke cases.
Find her online at @JohannaSeidenMD
- Check out our website at www.theneurotransmitters.com to sign up for emails, classes, and quizzes!
- Would you like to be a guest or suggest a topic? Email us at contact@theneurotransmitters.com
- Follow our podcast channel on π @neuro_podcast for future news!
- Find me on π @DrKentris
The views expressed do not necessarily represent those of any associated organizations. The information in this podcast is for educational and informational purposes only and does not represent specific medical/health advice. Please consult with an appropriate health care professional for any medical/health advice.
